Literature DB >> 8378311

Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.

L Tong1, S Pav, C Pargellis, F Dô, D Lamarre, P C Anderson.   

Abstract

The crystal structure of HIV-2 protease in complex with a reduced amide inhibitor [BI-LA-398; Phe-Val-Phe-psi (CH2NH)-Leu-Glu-Ile-amide] has been determined at 2.2-A resolution and refined to a crystallographic R factor of 17.6%. The rms deviation from ideality in bond lengths is 0.018 A and in bond angles is 2.8 degrees. The largest structural differences between HIV-1 and HIV-2 proteases are located at residues 15-20, 34-40, and 65-73, away from the flap region and the substrate binding sites. The rms distance between equivalent C alpha atoms of HIV-1 and HIV-2 protease structures excluding these residues is 0.5 A. The shapes of the S1 and S2 pockets in the presence of this inhibitor are essentially unperturbed by the amino acid differences between HIV-1 and HIV-2 proteases. The interaction of the inhibitor with HIV-2 protease is similar to that observed in HIV-1 protease structures. The unprotected N terminus of the inhibitor interacts with the side chains of Asp-29 and Asp-30. The glutamate side chain of the inhibitor forms hydrogen bonds with the main-chain amido groups of residues 129 and 130.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378311      PMCID: PMC47361          DOI: 10.1073/pnas.90.18.8387

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.

Authors:  A L Swain; M M Miller; J Green; D H Rich; J Schneider; S B Kent; A Wlodawer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 3.  Molecular biology of HIV.

Authors:  B M Peterlin; P A Luciw
Journal:  AIDS       Date:  1988       Impact factor: 4.177

4.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

5.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.

Authors:  P M Fitzgerald; B M McKeever; J F VanMiddlesworth; J P Springer; J C Heimbach; C T Leu; W K Herber; R A Dixon; P L Darke
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

Review 7.  Molecular targets for AIDS therapy.

Authors:  H Mitsuya; R Yarchoan; S Broder
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

8.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

Authors:  M Miller; J Schneider; B K Sathyanarayana; M V Toth; G R Marshall; L Clawson; L Selk; S B Kent; A Wlodawer
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

10.  Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.

Authors:  A G Tomasselli; J O Hui; T K Sawyer; D J Staples; C Bannow; I M Reardon; W J Howe; D L DeCamp; C S Craik; R L Heinrikson
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.486

View more
  11 in total

1.  Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.

Authors:  J Lescar; J Brynda; P Rezacova; R Stouracova; M M Riottot; V Chitarra; M Fabry; M Horejsi; J Sedlacek; G A Bentley
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

2.  Structure-based method for analyzing protein-protein interfaces.

Authors:  Ying Gao; Renxiao Wang; Luhua Lai
Journal:  J Mol Model       Date:  2003-11-22       Impact factor: 1.810

3.  Expression of soluble cloned porcine pepsinogen A in Escherichia coli.

Authors:  T Tanaka; R Y Yada
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

4.  Structure of equine infectious anemia virus proteinase complexed with an inhibitor.

Authors:  A Gustchina; J Kervinen; D J Powell; A Zdanov; J Kay; A Wlodawer
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

5.  Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease.

Authors:  Andrey Y Kovalevsky; John M Louis; Annie Aniana; Arun K Ghosh; Irene T Weber
Journal:  J Mol Biol       Date:  2008-09-20       Impact factor: 5.469

6.  Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors.

Authors:  Dana N Raugi; Robert A Smith; Geoffrey S Gottlieb
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

7.  Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

Authors:  Kevin Peterson; Sabelle Jallow; Sarah L Rowland-Jones; Thushan I de Silva
Journal:  AIDS Res Treat       Date:  2011-02-09

8.  Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease.

Authors:  Pierre Laville; Sandrine Fartek; Natacha Cerisier; Delphine Flatters; Michel Petitjean; Leslie Regad
Journal:  BMC Mol Cell Biol       Date:  2020-06-23

9.  Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet.

Authors:  Dhoha Triki; Mario Enrique Cano Contreras; Delphine Flatters; Benoit Visseaux; Diane Descamps; Anne-Claude Camproux; Leslie Regad
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

10.  Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases.

Authors:  Dhoha Triki; Telli Billot; Benoit Visseaux; Diane Descamps; Delphine Flatters; Anne-Claude Camproux; Leslie Regad
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.